Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | BRAF |
Variant | L597K |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | BRAF L597K lies within the protein kinase domain of the Braf protein (UniProt.org). L597K has been identified in the scientific literature (PMID: 33560788), but has not been biochemically characterized and therefore, its effect on Braf protein function is unknown (PubMed, May 2024). |
Associated Drug Resistance | |
Category Variants Paths |
BRAF mutant BRAF L597X BRAF L597K |
Transcript | NM_004333.6 |
gDNA | chr7:g.140753345_140753346delCTinsAA |
cDNA | c.1789_1790delCTinsAA |
Protein | p.L597K |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_004333.5 | chr7:g.140753345_140753346delCTinsAA | c.1789_1790delCTinsAA | p.L597K | RefSeq | GRCh38/hg38 |
NM_001378468.1 | chr7:g.140753345_140753346delCTinsAA | c.1789_1790delCTinsAA | p.L597K | RefSeq | GRCh38/hg38 |
NM_004333.6 | chr7:g.140753345_140753346delCTinsAA | c.1789_1790delCTinsAA | p.L597K | RefSeq | GRCh38/hg38 |
NM_001354609.1 | chr7:g.140753345_140753346delCTinsAA | c.1789_1790delCTinsAA | p.L597K | RefSeq | GRCh38/hg38 |
NM_001378473.1 | chr7:g.140749333_140749334delTTinsAA | c.1789_1790delTTinsAA | p.L597K | RefSeq | GRCh38/hg38 |
NM_001378474.1 | chr7:g.140753345_140753346delCTinsAA | c.1789_1790delCTinsAA | p.L597K | RefSeq | GRCh38/hg38 |
NM_001354609.2 | chr7:g.140753345_140753346delCTinsAA | c.1789_1790delCTinsAA | p.L597K | RefSeq | GRCh38/hg38 |
NM_001378472.1 | chr7:g.140749333_140749334delTTinsAA | c.1789_1790delTTinsAA | p.L597K | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
BRAF L597K | melanoma | predicted - sensitive | Cobimetinib + Vemurafenib | Case Reports/Case Series | Actionable | In a clinical case study, the combination of Cotellic (cobimetinib) and Zelboraf (vemurafenib) resulted in a partial response and clinical improvement in a patient with metastatic melanoma harboring BRAF L597K (PMID: 33560788). | 33560788 |